In THYM, KIF2C strongly correlated with CD8+ T cells with tumor suppressive effects and negatively correlated with CAFs, M2 macrophages, Tregs, and TIDE score, suggesting that KIF2C expression in THYM is a protective factor that predicts a better ICB response. This evidence concerns the gene CD8A and neoplasm.